Photo of Steve Kraus, Partner

Steve Kraus

Partner
Cambridge

Biography

Steve Kraus is a partner at Bessemer in the Cambridge office and a world-renowned healthcare investor. He is the author of Bessemer’s 10 Laws of Healthcare,  Benchmarks for Growing Health tech Businesses, and is a co-host of A Healthy Dose podcast. Steve currently sits on the boards of Bright Health Group, Headspace Health, Groups, Qventus, AspenRx, HouseRx, Oshi Health, Folx Health, Mural Health, and Alcresta.

Prior to joining Bessemer, Steve worked for a growth-stage, private equity firm and as a management consultant at Bain & Company. He has also worked on several different political campaigns throughout his career.

He serves as an Observer at Beth Israel Deaconess Medical Center, an advisor to Boston Children’s Hospital and the Harvard Business School’s Center for Entrepreneurship, and on the investment committees of BCBS Massachusetts and Rock Health.

Steve graduated from summa cum laude from Yale University and earned his MBA from Harvard, where he was a Baker Scholar.

Portfolio Highlights

View All Companies

“Innovating in healthcare is really hard and really rewarding. Make sure you work with people who understand the industry deeply and work in it for all the right reasons.”

Portfolio Companies

Indicates Enduring

Artemis Health

ACQUIRED BY: NOMI HEALTH
Close Info Window

Artemis Health

Artemis Health's next-generation data optimization platform enables benefits teams to quantify the impact of their programs, justify new and better programs for their members, and drive their benefits strategy.

Artemis Health was acquired by Nomi Health in January 2022.

ACQUIRED BY: NOMI HEALTH

Founded

2013

Partnered

2019

Roadmaps

Collective Medical

ACQUIRED BY: POINTCLICKCARE TECHNOLOGIES
Close Info Window

Collective Medical

Collective Medical empowers care teams to improve patient outcomes by closing the communication gaps that undermine patient care. Collective Medical was acquired by PointClickCare Technologies in December 2020.

ACQUIRED BY: POINTCLICKCARE TECHNOLOGIES

Founded

2005

Partnered

2017

Roadmaps

Liazon

ACQUIRED BY: TOWERS WATSON & CO.
Close Info Window

Liazon

Liazon is an online benefits store that operates private benefits exchange for businesses. In November 2013, Liazon was acquired by Towers Watson & Co.

ACQUIRED BY: TOWERS WATSON & CO.

Investors

Steve Kraus

Founded

2007

Partnered

2012

Roadmaps

Lumere

ACQUIRED BY: GLOBAL HEALTH EXCHANGE
Close Info Window

Lumere

Lumere (formerly Procured Health) is a software company which provides insights to health care variation and cost reduction. Lumere was acquired by Global Healthcare Exchange in 2020.

ACQUIRED BY: GLOBAL HEALTH EXCHANGE

Investors

Steve Kraus

Founded

2012

Partnered

2012

Roadmaps

Stromedix

ACQUIRED BY: BIOGEN IDEC.
Close Info Window

Stromedix

Stromedix is a biomedical company focused on drugs for fibrosis, organ failure and cancer. In 2012, Stromedix was acquired by Biogen Idec.

ACQUIRED BY: BIOGEN IDEC.

Verastem

NASDAQ: VSTM
Close Info Window

Verastem

Verastem is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. In January 2012, Verastem went public (NASDAQ: VSTM).

NASDAQ: VSTM

Investors

Steve Kraus

Founded

2010

Partnered

2010

Roadmaps

Verata Health

ACQUIRED BY: OLIVE
Close Info Window

Verata Health

Verata Health is the developer of an artificial intelligence platform intented to improve the prior authorization process for private practices, hospitals, and health systems. Verata Health was acquired by Olive in December 2020.

ACQUIRED BY: OLIVE

Investors

Steve Kraus

Founded

2017

Partnered

2019

Roadmaps

Welltok

ACQUIRED BY: VIRGIN PULSE
Close Info Window

Welltok

Welltok is a enterprise SaaS company that delivers the healthcare industry’s consumer activation platform.

Welltok was acquired by Virgin Pulse in November 2021.

ACQUIRED BY: VIRGIN PULSE

Investors

Steve Kraus

Founded

2009

Partnered

2014

Roadmaps

Insights & News